The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
EPHEDRINE-HAMELN (Hameln Pharma Pty Ltd)
Product name
EPHEDRINE-HAMELN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
128 (255 working days)
Active ingredients
ephedrine hydrochloride
Registration type
New generic medicine
Indication
The treatment of hypotension secondary to spinal anaesthesia